Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety, Tolerability, and Analgesic Efficacy of Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain

NCT01318369 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT01318369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01318369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety, Tolerability, and Analgesic Efficacy of Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2011
Completion date
May 31, 2013
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal pain, cannabinoid, chronic pancreatitis, tetrahydrocannabinol